Streetbeat News

FFNTF

4Front Ventures Corp

Employees

405

Industry

Medicinal and Botanical Manufacturing

Open

0.04

Mkt cap

35M

Volume

143K

High

0.04

P/E Ratio

-0.25

52-wk high

0.23

Low

0.03

Div yield

N/A

52-wk low

0.03

January saw significant executive and board changes in the cannabis industry. Flora Growth Corp.'s CEO, Clifford Starke, was elected chairman of the U.S. Hemp Roundtable. 4Front Ventures and The Cannabist Company Holdings announced new CEOs. Organigram Holdings and other companies made board appointments, while MedMen Enterprises and BZAM Ltd. saw departures. Trulieve Cannabis appointed a new COO, and other companies expanded their executive teams.

Portfolio Pulse from Jelena Martinovic

February 02, 2024 | 4:01 pm

The article lists the cannabis stocks that experienced significant gains and losses on January 31, 2024. Notable gainers include Rhinomed, GrowLife, and Elixinol Wellness with increases of 200%, 100%, and 69.3% respectively. On the losing side, MedMen Enterprises and EVIO both plummeted by 99%. The article also mentions several other cannabis-related companies with varying degrees of price changes.

Portfolio Pulse from Benzinga Insights

January 31, 2024 | 9:30 pm

The article reports on the significant price movements of various cannabis-related stocks on January 30, 2024. Notable gainers include MedMen Enterprises, EVIO, Corbus Pharmaceuticals, and others, with MedMen and EVIO both closing up 9900.00% at $0.0001. On the losing side, Rhinomed led the declines with a 73.54% drop. The article lists both gainers and losers with their respective percentage changes and closing prices.

Portfolio Pulse from Benzinga Insights

January 30, 2024 | 9:30 pm

The article reports on the significant price movements of various marijuana stocks on January 29, 2024. Notable gainers include CordovaCann, Blueberries Medical, and 1933 Industries, with increases of 26.53%, 26.14%, and 15.88% respectively. Psychemedics, 4Front Ventures, and Canopy Growth also saw gains. On the losing side, EVIO plummeted by 99%, while Global Hemp Group and Corbus Pharmaceuticals experienced significant drops of 45.30% and 34.93%. The article was generated by Benzinga's automated content engine and reviewed by an editor.

Portfolio Pulse from Benzinga Insights

January 29, 2024 | 9:30 pm

Cannabis stocks experienced significant volatility on January 26, 2024, with Corbus Pharmaceuticals leading the gainers with a 240.88% increase, while Blueberries Medical topped the losers with a 27.49% decline. Other notable movers included SOL Global Investments, C21 Investments, and OrganiGram Holdings with substantial gains, and 1933 Industries, Target Group, and Item 9 Labs with notable losses.

Portfolio Pulse from Benzinga Insights

January 26, 2024 | 9:30 pm

On January 23, 2024, several cannabis stocks experienced significant price movements. MedMen Enterprises led the gainers with a 999900.00% increase, closing at $0.01, while Pharmadrug led the losers with a 25.23% decrease, closing at $0.03. Notable gainers included Cann Gr, Khiron Life Sciences, and Canopy Growth, with increases of 125.92%, 59.09%, and 5.22% respectively. Among the losers, Greenlane Holdings and OrganiGram Holdings saw declines of 5.20% and 3.96%. The article was generated by Benzinga's automated content engine.

Portfolio Pulse from Benzinga Insights

January 23, 2024 | 9:30 pm

On January 22, 2024, several cannabis-related stocks experienced significant price movements. Notable gainers included Cansortium, Global Hemp Group, and Blueberries Medical, with increases of 27.27%, 25.00%, and 18.18% respectively. Urban-gro, OrganiGram Holdings, and Psychemedics also saw gains on NASDAQ. Conversely, AusCann Group Holdings, EVIO, and Maple Leaf Green World were among the biggest losers, with AusCann's shares plummeting by 59.42%. Corbus Pharmaceuticals and Eastside Distilling also experienced declines on NASDAQ.

Portfolio Pulse from Benzinga Insights

January 22, 2024 | 9:30 pm

Cannabis stocks experienced significant movements on January 19, 2024. EVIO led the gainers with a 9900.00% increase, while Rocky Mountain High topped the losers with a 21.62% decline. Notable gainers included Genetic Technologies, OrganiGram Holdings, and Cara Therapeutics, with increases of 42.16%, 10.72%, and 4.80% respectively. Among the losers, Corbus Pharmaceuticals and Greenlane Holdings saw declines of 4.91% and 3.32%.

Portfolio Pulse from Benzinga Insights

January 19, 2024 | 9:30 pm

The cannabis sector experienced bearish sentiment on January 18, 2024, with a mix of gainers and losers. Notable gainers included Genetic Technologies (GENE) and Urban-gro (UGRO), while significant losers were Aurora Cannabis (ACB), GrowGeneration (GRWG), OrganiGram Holdings (OGI), Tilray Brands (TLRY), Neptune Wellness Solutions (NEPT), Canopy Growth (CGC), Corbus Pharmaceuticals (CRBP), and Village Farms International (VFF).

Portfolio Pulse from Benzinga Insights

January 18, 2024 | 9:30 pm

On January 17, 2024, several cannabis stocks experienced significant price movements. AusCann Group Holdings led the gainers with a 187.50% increase, while MedMen Enterprises and GreenGro Technologies were the biggest losers, both dropping by over 99%. Other notable gainers include Khiron Life Sciences and Maple Leaf Green World, with increases of 54.29% and 32.45%, respectively. Among the losers, 22nd Century Group and OrganiGram Holdings saw declines of 14.72% and 7.89%. The movements reflect the volatile nature of the cannabis market.

Portfolio Pulse from Benzinga Insights

January 17, 2024 | 9:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.